Patent · US Active

Compounds and uses thereof for the modulation of hemoglobin

US9458139B2 · kind B2 · utility

44Cited by
31References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateOct 4, 2016
Priority date
Expiry dateMar 15, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.